Ratio of Creatine Kinase to Alanine Aminotransferase as a Biomarker of Acute Liver Injury in Dystrophinopathy - Concepedia

Concepedia

Publication | Open Access

Ratio of Creatine Kinase to Alanine Aminotransferase as a Biomarker of Acute Liver Injury in Dystrophinopathy

DOI Full Paper Access

25

Citations

28

References

2018

Year

Liang Wang, Menglong Chen, Min Xu, Jing Li, Pinning Feng, Ruojie He, Yuling Zhu, Huan Li, Jinfu Lin, Cheng Zhang

Disease Markers

Abstract

CK/ALT is a potential biomarker for the differential evaluation of acute liver injury in dystrophic mice, which highlights the value to further evaluate the practice of CK/ALT in dystrophinopathy patients.

References

	Year	Citations
Data on the distribution of fibre types in thirty-six human muscles Mark Johnson, J. P. Polgár, David R. Appleton Journal of the Neurological Sciences Muscle FunctionKinesiologyMuscle InjurySkeletal MusclePhysiology	1973	2.2K
Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb Thomas J. Burkholder, Brian Fingado, Stéphanie Baron, Journal of Morphology	1994	541
Muscular exercise can cause highly pathological liver function tests in healthy men Jonas Pettersson, Ulf Hindorf, Paula Persson, British Journal of Clinical Pharmacology	2007	343
Mildly elevated liver transaminase levels in the asymptomatic patient. Paul Giboney PubMed PathologyMild ElevationsHepatic DisordersLiver Transaminase LevelsHepatotoxicity	2005	306
Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method Evangelia Jockers-Wretou, Gerhard Pfleiderer Clinica Chimica Acta Signal TransductionBiochemistryMedicineNatural SciencesBioanalysis	1975	198
The role of fibrosis in Duchenne muscular dystrophy. Werner Klingler, Karin Jurkat‐Rott, Frank Lehmann‐Horn, PubMed Muscle FunctionVulnerable MyofibresPathologyNeuromusculoskeletal DisorderMuscle Physiology	2012	175
Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia William Duddy, Stéphanie Duguez, Helen Johnston, Skeletal Muscle	2015	134
A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy Nicholas P. Whitehead, K. Bible, Marvin E. Adams, Proceedings of the National Academy of Sciences	2015	113
Utility of cystatin C to monitor renal function in duchenne muscular dystrophy Laurence Viollet, Susan Gailey, David J. Thornton, Muscle & Nerve	2009	107
Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy Peter M. Burch, Oksana Pogoryelova, Richard A. Goldstein, Journal of Neuromuscular Diseases	2015	97

Page 1